Calanolide A (original) (raw)

About DBpedia

Calanolide A is an experimental non-nucleoside reverse transcriptase inhibitor (NNRTI). This compound was extracted from the tree Calophyllum lanigerum, of variety austrocoriaceum, in Lundu, Malaysian state of Sarawak in 1992 by United States National Cancer Institute (NCI). Due to rarity of the raw materials and low yield of the active ingredient, total synthesis of the compound was devised in 1996. For the same reason, its sister compound (-)-Calanolide B (also known as Costatolide) have been tauted as replacement. As a result of the discovery of Calanolide A, Sarawak Medichem pharmaceuticals company was established as a joint venture between US-based MediChem Research Inc and Craun Research Sdn Bhd, a company owned by the Sarawak state government. In 2006, Craun Research acquired Sarawa

thumbnail

Property Value
dbo:abstract Calanolide A is an experimental non-nucleoside reverse transcriptase inhibitor (NNRTI). This compound was extracted from the tree Calophyllum lanigerum, of variety austrocoriaceum, in Lundu, Malaysian state of Sarawak in 1992 by United States National Cancer Institute (NCI). Due to rarity of the raw materials and low yield of the active ingredient, total synthesis of the compound was devised in 1996. For the same reason, its sister compound (-)-Calanolide B (also known as Costatolide) have been tauted as replacement. As a result of the discovery of Calanolide A, Sarawak Medichem pharmaceuticals company was established as a joint venture between US-based MediChem Research Inc and Craun Research Sdn Bhd, a company owned by the Sarawak state government. In 2006, Craun Research acquired Sarawak MediChem. In 2016, Craun Research announced the completion of Phase I clinical trials for Calanolide A. (en)
dbo:casNumber 142632-32-4
dbo:chEMBL 267447
dbo:fdaUniiCode S5A9TQN46W
dbo:pubchem 64972
dbo:thumbnail wiki-commons:Special:FilePath/Calanolide_A.svg?width=300
dbo:wikiPageID 14562897 (xsd:integer)
dbo:wikiPageLength 21159 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID 1123116789 (xsd:integer)
dbo:wikiPageWikiLink dbr:Calophyllum dbr:Sarawak dbr:Sarawak_Biodiversity_Centre dbr:Enantiomer dbr:Rifampicin dbr:Cytochrome_P450 dbr:Umbelliferone dbr:Structural_analog dbr:University_of_Illinois_at_Chicago dbr:Racemic_mixture dbr:12-O-Tetradecanoylphorbol-13-acetate dbc:Enones dbc:Lactones dbc:Secondary_alcohols dbr:Competitive_inhibition dbr:Convention_on_Biological_Diversity dbr:Stereochemistry dbr:Government_of_Sarawak dbr:Epstein–Barr_virus dbr:Annuar_Rapaee dbr:Lemont,_Illinois dbr:Liver dbr:Lundu,_Sarawak dbr:Malaysia dbr:Singapore_Botanic_Gardens dbr:Streptomycin dbr:Total_synthesis dbr:Tuberculosis dbr:HIV dbr:Harvard_University_Herbaria dbc:Antiretroviral_drugs dbr:Foscarnet dbr:Raji_cell dbr:Reverse_transcriptase dbr:Viral_replication dbr:Harvard_University dbr:Isoniazid dbr:Hydrogenation dbr:Bioprospecting dbr:Heteroatom dbr:CYP3A4 dbr:National_Cancer_Institute dbr:Nevirapine dbr:Wagner–Meerwein_rearrangement dbr:Optical_rotation dbr:Sago dbr:Phases_of_clinical_research dbr:Structure–activity_relationship dbr:Non-nucleoside_reverse_transcriptase_inhibitor dbr:L-phenylalanine dbr:Phosphonoformic_acid dbr:Contract_research_organizations dbr:File:Craun_Research_Sdn_Bhd_signage.jpg
dbp:atcPrefix none (en)
dbp:c 22 (xsd:integer)
dbp:casNumber 142632 (xsd:integer)
dbp:chembl 267447 (xsd:integer)
dbp:chemspiderid 58497 (xsd:integer)
dbp:h 26 (xsd:integer)
dbp:iupacName 2 (xsd:integer) 12 (xsd:integer) -[10R,11S,12S]-10,11-trans-dihydro- (en)
dbp:metabolism Hepatic (en)
dbp:o 5 (xsd:integer)
dbp:proteinBound >97% (en)
dbp:pubchem 64972 (xsd:integer)
dbp:smiles O=C/4Oc2c\CCCC (en)
dbp:stdinchi 1 (xsd:integer)
dbp:stdinchikey NIDRYBLTWYFCFV-FMTVUPSXSA-N (en)
dbp:unii S5A9TQN46W (en)
dbp:wikiPageUsesTemplate dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Fdacite dbt:HIVpharm
dct:subject dbc:Enones dbc:Lactones dbc:Secondary_alcohols dbc:Antiretroviral_drugs
gold:hypernym dbr:Inhibitor
rdf:type owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatMolecularFormulas yago:Abstraction100002137 yago:Agent114778436 yago:Alcohol107884567 yago:Beverage107881800 yago:CausalAgent100007347 yago:Communication100033020 yago:Drug103247620 yago:DrugOfAbuse103248958 yago:Fluid114939900 yago:Food100021265 yago:Formula106816935 yago:Liquid114940386 yago:Matter100020827 yago:Message106598915 yago:MolecularFormula106817173 yago:Part113809207 yago:PhysicalEntity100001930 yago:Relation100031921 dbo:Drug yago:Statement106722453 yago:Substance100019613 yago:Substance100020090 yago:WikicatAlcohols umbel-rc:DrugProduct
rdfs:comment Calanolide A is an experimental non-nucleoside reverse transcriptase inhibitor (NNRTI). This compound was extracted from the tree Calophyllum lanigerum, of variety austrocoriaceum, in Lundu, Malaysian state of Sarawak in 1992 by United States National Cancer Institute (NCI). Due to rarity of the raw materials and low yield of the active ingredient, total synthesis of the compound was devised in 1996. For the same reason, its sister compound (-)-Calanolide B (also known as Costatolide) have been tauted as replacement. As a result of the discovery of Calanolide A, Sarawak Medichem pharmaceuticals company was established as a joint venture between US-based MediChem Research Inc and Craun Research Sdn Bhd, a company owned by the Sarawak state government. In 2006, Craun Research acquired Sarawa (en)
rdfs:label Calanolide A (en)
owl:sameAs freebase:Calanolide A yago-res:Calanolide A wikidata:Calanolide A dbpedia-sh:Calanolide A dbpedia-sr:Calanolide A https://global.dbpedia.org/id/4egoZ
prov:wasDerivedFrom wikipedia-en:Calanolide_A?oldid=1123116789&ns=0
foaf:depiction wiki-commons:Special:FilePath/Calanolide_A.svg wiki-commons:Special:FilePath/Craun_Research_Sdn_Bhd_signage.jpg
foaf:isPrimaryTopicOf wikipedia-en:Calanolide_A
is dbo:wikiPageWikiLink of dbr:Bintangor,_Sarawak dbr:C22H26O5 dbr:Calophyllum_brasiliense dbr:F._Dean_Toste
is foaf:primaryTopic of wikipedia-en:Calanolide_A